HomeGENX • CVE
add
Genix Pharmaceuticals Corp
Previous close
$0.025
Year range
$0.020 - $0.065
Market cap
1.53M CAD
Avg Volume
14.80K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.73K | -20.99% |
Net income | -83.50K | -1.62% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -32.45K | 19.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.64K | -54.69% |
Total assets | 27.11K | -88.35% |
Total liabilities | 1.45M | -9.03% |
Total equity | -1.43M | — |
Shares outstanding | 59.22M | — |
Price to book | -1.25 | — |
Return on assets | -237.94% | — |
Return on capital | 20.97% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | -83.50K | -1.62% |
Cash from operations | -15.68K | 65.86% |
Cash from investing | — | — |
Cash from financing | 16.02K | -65.64% |
Net change in cash | 335.00 | -51.17% |
Free cash flow | -20.65K | 50.01% |
About
Founded
1993
Headquarters
Website
